Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis

Pain Physician

Volumn 16, Issue 2, 2013, Pages 109-116

  Lee, Cheng Ling ^a   Kuo, Hann Chorng ^a  

^a TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Bladder pain syndrome; Botulinum toxin; Hunner's ulcer; Interstitial cystitis; Intravesical treatment

Indexed keywords

BOTULINUM TOXIN A; CD68 ANTIGEN; ONABOTULINUMTOXIN; STEM CELL FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLADDER BIOPSY; CAUTERIZATION; CONTROLLED STUDY; CYSTALGIA; CYSTOSCOPY; FEMALE; HUMAN; HUMAN TISSUE; INTERSTITIAL CYSTITIS; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MICTURITION; NOCTURIA; NONULCER TYPE INTERSTITIAL CYSTITIS; O LEARY SANT SCORE; SCORING SYSTEM; SYMPTOMATOLOGY; TREATMENT FAILURE; TREATMENT OUTCOME; ULCER TYPE INTERSTITIAL CYSTITIS; URINE FLOW RATE; URINE VOLUME; URODYNAMICS; VISUAL ANALOG SCALE;

ADMINISTRATION, INTRAVESICAL; ADULT; AGED; BOTULINUM TOXINS, TYPE A; CYSTITIS, INTERSTITIAL; FEMALE; HUMANS; MIDDLE AGED; NEUROMUSCULAR AGENTS; ULCER;

EID: 84875330644     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Hanno P. Interstitial cystitis and related diseases. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ (eds). Campbell's Urology. 7th ed. WB Saunders, Co., Philadelphia, PA, 1998, pp 631-662.
2. Nigro DA, Wein AJ, Foy M, Parsons CL, Williams M, Nyberg LM Jr, Landis JR, Cook YL, Simon LJ. Association among cystoscopic and urodynamic findings for women enrolled in the Interstitial Cystitis Data Base (ICDB) Study. Urology 1997; 49:86-92.
3. Hunner GL. A rare type of bladder ulcer in women: Report of cases. Tans South Surg Gynecol Assoc 1915; 27:247-292.
4. Nickle JC. Interstitial cystitis: A chronic pelvic pain syndrome. Med Clin North Am 2004; 88:467-481.
5. Denson MA, Griebling TL, Cohen MB, Kreder KJ. Comparison of cystoscopic and histological findings in patients with suspected interstitial cystitis. J Urol 2000; 164:1908-1911.
6. Koziol JA, Adams HP, Frutas A. Discrimination between the ulcerous and the nonulcerous forms of interstitial cystitis by noninvasive findings. J Urol 1996; 155:87-90.
7. Tomaszewski JE, Landi JR, Russack V, Williams TM, Wang LP, Hardy C, Brens-inger C, Matthews YL, Abele ST, Kusek JW, Nyberg LM; Interstitial Cystitis Database Study Group. Biopsy features are associated with primary symptoms in interstitial cystitis: Results from the interstitial cystitis database study. Urology 2001; 57:67-81.
8. Braunstein R, Shapiro E, Kaye J, Moldwin R. The role of cystoscopy in the diagnosis of Hunner's ulcer disease. J Urol 2008; 180:1383-1386.
9. Tyagi P, Killinger K, Tyagi V, Nirmal J, Chancellor M, Peters KM. Urinary che-mokines as non-invasive predictors of ulcerative interstitial cystitis. J Urol 2012; 187:2243-2248.
10. Hanno PM, Sant GR. Clinical highlights of the national Institute of Diabetes and Digestive and Kidney Diseases/Interstitial Cystitis Association scientific conference on interstitial cystitis. Urology 2001; 57:2-6.
11. Shie JH, Kuo HC. Higher levels of cell apoptosis and abnormal E-cadherin expression in the urothelium are associated with inflammation in patients with interstitial cystitis/painful bladder syndrome. BJU Int 2011; 108:E136-E141.
12. Brady CM, Apostolidis A, Harper M, Yiangou Y, Beckett A, Jacques TS, Freeman A, Scaravilli F, Fowler CJ, Anand P. Parallel changes in bladder subu-rothelial vanilloid receptor TRPV1 and pan-neuronal marker PGP9.5 immuno-reactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatment. BJU Int 2004; 93:770-776.
13. Cockayne DA, Hamilton SG, Zhu OM, Dunn PM, Zhong Y, Novakovic S, Malmberg AB, Cain G, Berson A, Kas-sotakis L, Hedley L, Lachnit WG, Burn-stock G, McMahon SB, Ford AP. Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature 2000; 407:1011-1015.
14. Chuang YC, Yoshimura N, Huang CC, Chiang PH, Chancellor MB. Intravesi-cal botulinum toxin A administration produces analgesia against acetic acid induced bladder pain response in rats. J Urol 2004; 172:1529-1532.
15. Giannantoni A, Di Stasi SM, Nardicchi V, Zucchi A, Macchioni L, Bini V, Goracci G, Porena M. Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity. J Urol 2006; 175:2341-2344.
16. Khera M, Somogyi GT, Kiss S, Boone TB, Smith CP. Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury. Neuro-chem Int 2004; 45:987-993.
17. Rapp DE, Turk KW, Bales GT, Cook SP. Botulinum toxin type a inhibits cal-citonin gene-related peptide release from isolated rat bladder. J Urol 2006; 175:1138-1142.
18. Cayan S, Coskun B, Bozlu M, Acar D, Ak-bay E, Ulusoy E. Botulinum toxin type A may improve bladder function in a rat chemical cystitis model. Urol Res 2003; 30:399-404.
19. Steers WD, Tuttle JB. Mechanisms of disease: The role of nerve growth factor in the pathophysiology of bladder disorders. Nat Clin Pract Urol 2006; 3:101-110.
20. Apostolidis A, Papat R, Yiangou Y, Cockayne D, Ford AP, Davis JB, Dasgupta P, Fowler CJ, Anand P. Decreased sensory receptors P2X3 and TRPV1 in suburothe-lial nerve fibers following intradetrusor injection of botulinum A toxin for human detrusor overactivity. J Urol 2005; 173:977-983.
21. Reitz A, Stöhrer M, Kramer G, Del Popolo G, Chartier-Kastler E, Pannek J, Burg-dörfer H, Göcking K, Madersbacher H, Schumacher S, Richter R, von Tobel J, Schurch B. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogen-ic detrusor overactivity. Eur Urol 2004; 45:510-515.
22. Smith CP, Radziszewski P, Borkowski A, Somogyi GT, Boone TB, Chancellor MB. Botulinum toxin A has antinociceptive effects in treating interstitial cystitis. Urology 2004; 64:871-875.
23. Giannantoni A, Costantini E, Di Stasi SM, Tascini MC, Bini V, Porena M. Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: A pilot study. Eur Urol 2006; 49:704-709.
24. Kuo HC. Preliminary results of suburo-thelial injection of botulinum A toxin in the treatment of chronic interstitial cystitis. Urol Int 2005; 75:170-174.
25. Cui M, Aoki KR. Botulinum toxin type A (BTX-A) reduces inflammatory pain in the rat formalin model. Cephalalgia 2000; 20:414-418.
26. Giannantoni A, Porena M, Costan-tini E, Zucchi A, Mearini L, Mearini E. Botulinum A toxin intravesical injection in patients with painful bladder syndrome: 1-year followup. J Urol 2008; 179:1031-1034.
27. Kuo HC. Repeated onabotulinumtoxin-A injections provide better results than single injection in treatment of painful bladder syndrome. Pain Physician 2013; 16:E15-E23.
28. Homma Y, Ueda T, Tomoe H, Lin AT, Kuo HC, Lee MH, Lee JG, Kim DY, Lee KS; Interstitial cystitis guideline committee. Clinical guidelines for interstitial cystitis and hypersensitive bladder syndrome. Int J Urol 2009; 16:597-615.
29. O'Leary MP, Sant GR, Fowler FJ Jr, Whit-more KE, Spolarich-Kroll J. The interstitial cystitis symptom index and problem index. Urology 1997; 49:58-63.
30. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A; Standardisation Subcommittee of the International Continence Society. The standardisation of terminology of lower urinary tract function: Report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21:167-178.
31. Parsons CL. The potassium sensitivity test: A new gold standard for diagnosing and understanding the pathophysiology of interstitial cystitis. J Urol 2009; 182:432-434.
32. Nickel JC, Barkin J, Forrest J, Mosbaugh PG, Hernandez-Graulau J, Kaufman D, Lloyd K, Evans RJ, Parsons CL, Atkinson LE; Elmiron Study Group. Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis. Urology 2005; 65:654-658.
33. Kuo HC, Chancellor MB. Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hy-drodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome. BJU Int 2009; 104:657-661.
34. Liu HT, Kuo HC. Intravesical botulinum toxin A injections plus hydrodistension can reduce nerve growth factor production and control bladder pain in interstitial cystitis. Urology 2007; 70:463-468.
35. Pinto R, Lopes T, Frias B, Silva A, Silva JA, Silva CM, Cruz C, Cruz F, Dinis P. Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis. Eur Urol 2010; 58:360-365.
36. Johansson SL, Fall M. Clinical features and spectrum of light microscopic changes in interstitial cystitis. J Urol 1990; 143:1118-1124.
37. Zhang CO, Li ZL, Kong CZ. APF, HB-EGF, and EGF biomarkers in patients with ulcerative vs. non-ulcerative interstitial cystitis. BMC Urol 2005; 5:7.
38. Rössberger J, Fall M, Peeker R. Long-term results of reconstructive surgery in patients with bladder pain syndrome/ interstitial cystitis: Subtyping is imperative. Urology 2007; 70:638-642.
39. Rofeim O, Hom D, Freid RM, Moldwin RM. Use of the neodymium: YAG laser for interstitial cystitis: A prospective study. J Urol 2001; 166:134-136.
40. Soucy F, Grégoire M. Efficacy of predni-sone for severe refractory ulcerative interstitial cystitis. J Urol 2005; 173:841-843.
41. Cox M, Klutke JJ, Klutke CG. Assessment of patient outcomes following submucosal injection of triamcinolone for treatment of Hunner's ulcer subtype interstitial cystitis. Can J Urol 2009; 16:4536-4540.
42. Tanaka T, Kawashima H, Makino T, Kamikawa S, Kato N, Nakatani T. Hyperbaric oxygen therapy for interstitial cystitis resistant to conventional treatments. Int J Urol 2007; 14:563-565.
43. Tanaka T, Nitta Y, Morimoto K, Nishika-wa N, Nishihara C, Tamada S, Kawashi-ma H, Nakatani T. Hyperbaric oxygen therapy for painful bladder syndrome/ interstitial cystitis resistant to conventional treatments: Long-term results of a case series in Japan. BMC Urol 2011; 11:11.